Hair Fall Nightmare Passé, here comes Non-Surgical Super Treatment

New Delhi:  Hair fall nightmare is passé, thanks to a new none surgical treatment. It is great good news that hair loss is no longer a headache. An innovative, breakthrough treatment for hair restoration has been introduced — Meta Cell Plasma Treatment (MCT). This is the world’s first treatment that uses autologous exosomes derived from the body’s own Platelet-Rich Plasma (PRP).

This FDA and CE approved non-invasive treatment has caught the imagination of those struggling with the trauma of untimely hair loss as outcomes are visible in less time. It improves both hair and scalp health.  There is no question of side effects.

This revolutionary treatment not only promotes new hair growth but also improves scalp health. The best part is it’s a non-surgical procedure, meaning no incisions or invasive steps are involved. Kaya Clinics are the pioneer chain of clinics to bring this to India.

The exosomes used in MCT help repair damaged cells in the scalp. These are injected directly into the scalp using a specialized technique, strengthening hair follicles and stimulating new hair growth. According to doctors, this treatment starts showing results within just three sessions, with visible improvements in 4 to 6 months. It involves minimal discomfort and downtime, making it an easy and practical solution.

Individuals experiencing hair fall or hair thinning, young people with receding hairlines and people with deteriorating scalp health can reap benefit from this brand new treatment.

Dr. Aparna Santhanam, Dermatologist and Head of Medical Operations at Kaya Limited, shared her excitement about the launch, stating, “The introduction of Meta Cell Plasma Treatment (MCT) represents a true breakthrough in the field of hair restoration through cutting-edge regenerative medicine. By utilizing the advanced regenerative power of autologous exosomes, we are offering our patients the most scientifically backed treatment that not only stimulates hair growth but also promotes scalp health, leading to healthier, fuller hair. This is an exciting new chapter in non-surgical aesthetic hair restoration treatments for patients of different ages and genders suffering from hair loss.”

Nishant Nayyar, Head of Marketing and Vice President at Kaya Limited, added,“Hair loss has become a growing concern among young Indians, significantly affecting both men and women. Recent research reveals that over 50% of men experiencing hair loss are below the age of 25, and about 33% aged 21–25 already face advanced stages of thinning. At Kaya, we’re proud to introduce Meta Cell Plasma Treatment (MCT), a revolutionary, science-backed solution designed to address hair loss effectively. As the first clinic chain in the industry to offer this innovative treatment in India, our commitment remains to deliver transformative, clinically proven results and to foster proactive awareness around hair and scalp health.”

Related Posts

  • Pharma
  • May 15, 2025
  • 47 views
Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

Andhra Pradesh chief minister N Chandrababu Naidu on Wednesday launched Bharat Biotech group company Biovet’s new vaccine against the lumpy skin disease (LSD) in dairy cattle and buffaloes, the company…

  • Pharma
  • May 14, 2025
  • 104 views
DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

The Drugs Technical Advisory Board (DTAB) has directed the Central drug regulator to take up the matter related to withdrawal of product license for antibiotic fixed dose combinations (FDCs), which…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

India’s anti-obesity drug market quadruples in five years on lifestyle disease surge

India’s anti-obesity drug market quadruples in five years on lifestyle disease surge

3 held with 60,000 tramadol tablets

3 held with 60,000 tramadol tablets

Indian Pharma May See Limited Short-Term Impact from US Drug Pricing Order

Indian Pharma May See Limited Short-Term Impact from US Drug Pricing Order

Hip Hip No Hurray: Steroid Misuse Linked To Rising Damage In Youths

Hip Hip No Hurray: Steroid Misuse Linked To Rising Damage In Youths